The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
PEARLS: A multicenter phase II/III trial of extended field radiotherapy for androgen-sensitive prostate cancer patients with PSMA‐avid pelvic and para-aortic lymph nodes at presentation.
 
Julia Murray
Honoraria - Astellas Pharma; Bayer UK; Elekta; Ferring; Janssen Oncology
Consulting or Advisory Role - Bayer; Ferring
 
Clare Cruickshank
No Relationships to Disclose
 
Thomas Bird
No Relationships to Disclose
 
Philip Bell
No Relationships to Disclose
 
John Braun
No Relationships to Disclose
 
Dave Chuter
No Relationships to Disclose
 
Reena Davda
No Relationships to Disclose
 
Miguel Reis Ferreira
No Relationships to Disclose
 
Clare Griffin
No Relationships to Disclose
 
Nabil Hujairi
No Relationships to Disclose
 
Alan Melcher
Honoraria - Amgen; Bristol-Myers Squibb; Merck Serono; Turnstone Bio
Research Funding - AstraZeneca; Bristol-Myers Squibb; Oncolytics
 
Elizabeth Miles
No Relationships to Disclose
 
Olivia Naismith
No Relationships to Disclose
 
Jan Rekowski
No Relationships to Disclose
 
John Staffurth
Consulting or Advisory Role - Astellas Oncology; Novartis
 
Isabel Syndikus
Honoraria - AstraZeneca; Bristol-Myers Squibb/Pfizer; Janssen; Roche
Travel, Accommodations, Expenses - Bayer
 
Alison Tree
Honoraria - Accuray; Elekta; Varian Medical Systems
Research Funding - Accuray (Inst); Elekta (Inst); Varian Medical Systems (Inst)
 
Anna Wilkins
No Relationships to Disclose
 
Emma Hall
Research Funding - Accuray (Inst); Alliance Pharma (Inst); AstraZeneca (Inst); Aventis Pharma (Inst); Bayer (Inst); Janssen-Cilag (Inst); Merck Sharpe & Dohme (Inst); Roche (Inst); Varian Medical Systems (Inst)